Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 815 results for "bayer ag"

Bayer (BAYRY) Q1 Earnings Beat Estimates, Retains View
Zacks.com

Bayer (BAYRY) Q1 Earnings Beat Estimates, Retains View

By Zacks Equity Research 42 minutes ago Bayer AG 's BAYRY first-quarter core earnings surged 13.9% year over year to €2.37 per share (approximately $2.61) and beat the Zacks Consensus Estimate of $2.48. [embedded ... Yahoo! Finance, 4 days ago
[x]  
TMC Net

Covestro at CHINAPLAS 2016: Debuts Under New Name

CHINA, Shanghai -- Covestro , formerly Bayer MaterialScience, is appearing under its new name for the first time at CHINAPLAS, one of the largest fairs for the rubber and plastics industry in Asia. At this occasion, Covestro looks back on a very ...
 Omnexus - SpecialChem2 days ago Covestro Debuts under new name at Chinaplas 2016  TMC Net6 days ago Covestro Makes A Strong Start to 2016  Yahoo! Finance3 days ago Covestro meets, then raises its eco goals  Plastics News1 week ago
[x]  

Research and Markets - Bayer Posts First-Quarter Profits of USD 3.83 Billion

From the Wires Apr. 26, 2016 11:02 AM DUBLIN , April 26, 2016 /PRNewswire/ -- Bayer AG has reported first-quarter profits of USD 3.83 billion before interest, taxes, depreciation and amortization. The earnings are the result of a strong ...
 Sys-Con India5 days ago Interim report for the first quarter of 2016: Bayer off to a successful start in 2016 Zwischenbericht zum 1. Quartal 2016: Bayer erfolgreich ins neue Geschäftsjahr gestartet  SeedQuest5 days ago
[x]  

Bayer Beats Estimates as Demand for Latest Drugs Stays Buoyant

(Bloomberg) -- Bayer AG reported first-quarter profit that rose, beating analysts expectations, as top-selling drugs Xarelto and Eylea continued to soar. Earnings before interest, taxes, depreciation and amortization, and excluding some costs, ...
 La Repubblica5 days ago
Ticker Report

Bayer A.G. reports Q1 results

News Editor Bayer A.G. (OTCPK:BAYZF): Q1 EPS of €1.83 Revenue of €11.94B (+0.5% Y/Y). Comments (0) Be the first to comment All (0) Author's Picks () Load All Comments DJIA (DIA) S&P 500 (SPY) ETF Hub ETF Screener: Search and ...
 Seeking Alpha5 days ago Jefferies Group Weighs in on Bayer AG's Q1 2016 Earnings (BAYRY)  Ticker Report1 week ago EPA Approves Bayer's Absolute MAXX Fungicide  USAgNet1 week ago Research Analysts Offer Predictions for Bayer AG's Q1 2016 Earnings (BAYRY)  American Banking News - Forex1 week ago
Bloomberg

Bayer Profit Beats Estimates as Newest Drugs Buoy Demand

Bayer AG reported first-quarter profit that beat analysts estimates as top-selling drugs Xarelto and Eylea continued to soar. Earnings before interest, taxes, depreciation and amortization, and excluding some costs, climbed 16 percent to 3.40 ...
 Bloomberg5 days ago
Irish Times

Bayer beats profit estimates on strong drug sales

Germany's largest company says sales of top-selling drugs Xarelto and Eylea continue to soar Bayer AG, Germany's largest company, reported first-quarter profit that beat analysts estimates as top-selling drugs Xarelto and Eylea continued to ...
 Irish Times5 days ago
LifeHealthPro

Germany Is New Battlefield for Drugmakers Facing Price Scrutiny

Roche says innovative medicines are made available in Germany Novo Nordisk, Bayer pulled key new drugs from the nation Germany, Europe's largest market for drugs, is emerging as a new front in the battle on drug pricing for pharmaceutical ...
 Bloomberg6 days ago

Monsanto surges as parent company holds talks to buy Bayer AG

, a wholly-owned subsidiary of the US-based Monsanto, surged over 15 per cent on Wednesday on reports that the parent company may buy the agri-chemical business of German-based Bayer AG. Reacting to the development, the scrip gained 15.6 per cent to hit a ...
 Economic Times1 month ago
Vietnamese Investment Review

Arterial Thrombosis Pipeline Report H1 2016 - Review of the Drug Profiles from Astellas Pharma, AstraZeneca, Bayer, Bristol-Myers Squibb, Eisai Co., Johnson & Johnson & Sanofi - Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "Arterial Thrombosis - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for ...
 Yahoo! Finance UK and Ireland2 days ago Raynauds Disease - Pipeline Review, H1 2016 Featuring Allergan, Apricus Biosciences, Bayer, Covis Pharmaceuticals & Human Stem Cells Institute - Research and Markets  4 Traders1 week ago Global Plastic Coatings Market Report 2015-2020 - Analysis, Technologies & Forecasts - Key Vendors: AkzoNobel, Bayer Material Sciences, Plastic Coatings Limited - Research and Markets  Business Wire1 week ago GLOBAL AGROCHEMICALS MARKET REPORT 2015-2020 - ANALYSIS, TECHNOLOGIES & FORECASTS - KEY VENDORS : Syngenta, Bayer CropScience, BASF - Research and Markets  4 Traders1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bayer ag
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less